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Abstract
Purpose: First-pass perfusion cardiovascular magnetic resonance (CMR) is increasingly being utilized in both clinical 
practice and research. However, the reproducibility of this technique remains incompletely evaluated, particularly in 
patients with severe coronary artery disease (CAD). The purpose of this study was to determine the inter-study 
reproducibility of adenosine stress CMR in patients with symptomatic multi-vessel CAD and those at low risk for CAD.
Methods: Twenty patients (10 with CAD, 10 low risk CAD) underwent two CMR scans 8 ± 2 days apart. Basal, mid and 
apical left ventricular short axis slices were acquired using gadolinium 0.05 mmol/kg at peak stress (adenosine, 140 μ/
kg/min, 4 min) and rest. Myocardial perfusion was evaluated qualitatively by assessing the number of ischemic 
segments, and semi-quantitatively by determining the myocardial perfusion reserve index (MPRi) using a normalized 
upslope method. Inter-study and observer reproducibility were assessed--the latter being defined by the coefficient of 
variation (CoV), which was calculated from the standard deviation of the differences of the measurements, divided by 
the mean. Additionally, the percentage of myocardial segments with perfect agreement and inter- and intra-observer 
MPRi correlation between studies, were also determined.
Results: The CoV for the number of ischemic segments was 31% with a mean difference of -0.15 ± 0.88 segments and 
91% perfect agreement between studies. MPRi was lower in patients with CAD (1.13 ± 0.21) compared to those with 
low risk CAD (1.59 ± 0.58), p = 0.02. The reproducibility of MPRi was 19% with no significant difference between 
patients with CAD and those with low risk CAD (p = 0.850). Observer reproducibility for MPRi was high: inter-observer 
CoV 9%, r = 0.93 and intra-observer CoV 5%, r = 0.94. For trials using perfusion CMR as an endpoint, an estimated 
sample size of 12 subjects would be required to detect a two-segment change in the number of ischemic segments 
(power 0.9, α 0.05).
Conclusions: Adenosine stress CMR, by qualitative and semi-quantitative normalized upslope analyses are 
reproducible techniques in both patients with multi-vessel CAD and those without known CAD. The robust inter-study 
reproducibility of perfusion CMR supports its clinical and research application.
Background
First-pass perfusion cardiovascular magnetic resonance
(CMR) allows non-invasive, rapid and ionizing-radiation-
free evaluation of myocardial perfusion and, in combina-
tion with other CMR techniques, provides a comprehen-
sive assessment of ischemic heart disease. Stress CMR
has high diagnostic accuracy with 91% sensitivity and
81% specificity reported for the detection of coronary
artery disease (CAD) [1]. Whilst single photon emission
computed tomography (SPECT) has been the most
widely utilized myocardial perfusion imaging modality,
CMR has demonstrated superiority for the detection of
CAD [2-4]. In particular, the improved spatial resolution
of CMR permits delineation of both small and diffuse
areas of subendocardial ischemia in the setting of mild to
moderate CAD and multi-vessel disease. In the largest
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multicenter clinical trial to date, the performance of CMR
was shown to be comparable to SPECT, and possibly
superior in the detection of three-vessel CAD [4]. Fur-
thermore, there is also emerging evidence for CMR as a
powerful coronary risk stratification tool. In patients with
known or suspected CAD, a normal stress CMR study
was shown to predict a 0.8% risk of cardiac death or non-
fatal myocardial infarction (MI) over a three year period,
whilst an abnormal result was shown to have a risk pro-
p o r t i o n a l  t o  t h e  d e g r e e  o f  a b n o r m a l i t y  [ 5 ] .  I n  a n o t h e r
study of patients presenting to the emergency depart-
ment with chest pain and a negative troponin, an abnor-
mal perfusion CMR scan had a 100% sensitivity and 91%
specificity for predicting CAD or an adverse cardiac
event at one year [6].
However, despite the appeal and anticipated future
application of perfusion CMR in both clinical and
research arenas, its reproducibility remains incompletely
evaluated, particularly in the severe CAD patient-popula-
tion. Reproducibility is a measure of the ability of a test to
produce the same result when applied under similar con-
ditions. Thus, reproducibility affects test precision, reli-
ability and is particularly important for tests that are used
in serial examinations to evaluate response to therapy or
for clinical monitoring. Knowing the inherent variability
of a technique is critical for interpreting the significance
of changes in measurements. For research applications,
tests with poor reproducibility require increased sample
sizes to reduce statistical error, which would unfavorably
increase study duration and costs.
Thus far, only three small studies have reported the
reproducibility of perfusion CMR [7-9]. In a study of 16
subjects (7 volunteers and 9 CAD patients), 21% and 41%
coefficient of variation (CoV) were reported for adenos-
ine stress CMR myocardial perfusion reserve index
(MPRi) by Fermi deconvolution and normalized upslope
analysis, respectively [7]. Muhling et al. [8] reported good
intra- (R = 0.80-0.85) and inter-observer (R = 0.83-0.88)
agreement for good quality images, using the quantitative
Fermi deconvolution method. In another study of the
qualitative analysis of dobutamine stress CMR in patients
with severe Canadian Cardiovascular Society class III-IV
angina, an inter-observer agreement, K, of 0.70, and low
intra-subject variability were reported [9]. These small
studies combined with high CMR diagnostic perfor-
mance suggest that perfusion CMR has reasonable repro-
ducibility. Further confirmation is, however, prudent,
particularly in clinical research where perfusion CMR is
increasingly being employed as a clinical endpoint and
accurate estimates of sample size are necessary. Further-
more, in addition to technical factors, reproducibility
may also be affected by biological conditions related to
the subject, and observer variability associated with sub-
jective assessments. Thus, reproducibility needs to be
evaluated in specific patient cohorts and also considered
in individual imaging centres due to varying local
reporter-expertise, imaging and contrast administration
protocols. The purpose of this study was to (1) determine
the reproducibility of qualitative and semi-quantitative
analyses of first-pass perfusion adenosine stress CMR in
patients with multi-vessel CAD versus those at low risk of
CAD and; (2) determine sample sizes required for trials
utilizing CMR myocardial perfusion as the primary end-
point.
Methods
The study was conducted between January and Septem-
ber 2009 with the approval of the St Vincent's Hospital
Human Research Ethics Committee and with written
informed consent from all patients.
Study Design
Patients underwent two CMR scans that were performed
on two separate occasions up to two weeks apart. CMR
scans were analyzed in random order by two reporters
(JM and SC) who were blinded to patients' details. Quali-
tative analysis was performed by consensus reporting and
semi-quantitative analysis was performed by a single
reporter (SC). Inter-study reproducibility was assessed by
comparing each patient's first and second scans. Addi-
tionally, a single short-axis slice (SA) was chosen from 20
randomly selected scans (10 case and 10 control) and
semi-quantitative analysis repeated by the same observer
(SC) and by a second observer (JM) to assess intra- and
inter-observer reproducibility, respectively.
Patient Population
Subjects were recruited into one of two groups: CAD
(case) or low risk CAD (control). Patients with CAD had
angiographically documented multi-vessel CAD (≥70%
stenosis in ≥2 major coronary vessels (>2 mm diameter))
and Canadian Cardiovascular Society class II-IV angina.
Classification of patients in the low risk CAD group was
based on them having a Framingham estimated 10 year
coronary heart disease risk of <10% [10]. Exclusion crite-
ria were alteration in CAD disease management or a new
coronary event in the period between the two CMR
examinations, contraindication to CMR including incom-
patible implants or severe claustrophobia, contraindica-
tion to adenosine including severe aortic stenosis,
conduction disorder (2:1 or greater atrioventricular
block) or severe bronchospasm, atrial fibrillation, uncon-
trolled heart failure, unstable angina or myocardial
infarction within 7 days, and significant renal impairment
(GFR ≤ 60 mL/min).
Cardiovascular Magnetic Resonance Imaging
CMR was performed at St George Hospital (Kogarah)
and Specialist Magnetic Resonance Imaging (Camper-Chih et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:42
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down), New South Wales on a 1.5 Tesla scanner (Philips
Intera, Best, The Netherlands) using a five channel car-
diac phased-array coil, cardiac gating and repeated breath
holds. Each examination involved an assessment of rest-
ing ventricular function, first-pass perfusion imaging and
late gadolinium enhancement (LGE) imaging for infarct
delineation.
Cardiac functional imaging was assessed by steady-
state free precession cine imaging (balanced turbo field
echo) in the long and short axis (SA) planes. The basal SA
slice was positioned at the level of the atrioventricular
valve in end-diastole, with all subsequent cines acquired
in 8 mm steps towards the apex. Parameters were: echo
time = 1.82 ms, repeat time = 3.6 ms, field of view = 350 ×
280 mm, read matrix = 192, phase matrix = 131, frames =
18 heart phases, flip angle = 70°.
Myocardial perfusion assessment was performed using
a T1-weighted single shot gradient echo sequence with a
saturation recovery pre-pulse. Parameters were: echo
time = 1.06 ms, repetition time = 3 ms, field of view = 360
× 360 mm, read matrix = 128, phase matrix = 97, recon-
struction matrix = 240, voxel size = 2.8 mm × 3.6 mm × 8
mm, flip angle = 20°. Images were acquired over 50
dynamic scans in standard basal, mid and apical SA slices
(Figure 1A). LGE imaging for infarct evaluation was per-
formed using an inversion recovery gradient-echo
sequence with inversion time optimized to null normal
myocardium (Figure 1B).
First-pass perfusion was assessed using three 0.05
mmol/kg boluses of gadolinium (Magnevist, Bayer Scher-
ing Pharma), administered at peak stress, 10 minutes later
at rest (Figure 1A) and immediately after completion of
rest imaging (Figure 1B). Gadolinium was delivered via a
power injector (Medrad Spectris) at 5 ml/sec with a 15 ml
saline flush. Stress was induced with an intravenous infu-
sion of 140 μg/kg/min adenosine (Adenoscan, Sanofi-
Synthelabo), commenced up to four minutes prior to
stress image acquisition. To ensure maximal vasodilatory
responses to adenosine, patients were asked to abstain
from caffeinated beverages for 24 hours prior.
Image Analyses
Image analysis was performed offline on a Philips View
Forum workstation using cardiac analysis software. Seg-
mental analysis was based on an 18-segment model:
radial division of each of the three SA slices into six seg-
ments with positioning of segment 6 at the insertion of
the right ventricle into the inferior septum of the LV (Fig-
ure 2A). Image quality was graded as 1 = suboptimal, 2 =
adequate, 3 = good. Measurements for each parameter
were reported as a global score (all three SA slice) and
according to left anterior descending (LAD), circumflex
(Cx) and right coronary artery (RCA) territories as per
AHA guidelines.
LV volumes, function and mass were derived by manual
tracing of epicardial and endocardial borders of contigu-
ous SA slices at end-diastole and end-systole. The end-
systolic phase was visually determined as the one with the
smallest cavity area and this was then used for all LV lev-
els. Papillary muscles and trabeculae with visible borders
in continuity with the endocardium were included in
both mass and volume analyses. Perfusion was assessed
qualitatively and semi-quantitatively. An automated
image stabilizer was applied to correct for gross cardiac
motion and images were windowed appropriately to opti-
mize visualization of perfusion defects, with the same
parameters used for both stress and rest images. Qualita-
tive analyses were performed by visual assessment of
myocardial signal enhancement in each segment. A per-
fusion defect was defined as any visible hypoenhance-
ment appearing after maximum signal intensity in the LV
blood pool (three frames after the arrival of contrast in
the LV cavity) and persisting for at least four dynamics.
Perfusion defects were graded by their transmural extent
(1 = normal, 2 = subendocardial defect, 3 = transmural
defect) and degree of hypoenhancement (1 = normal
(bright), 2 = probably abnormal (grey defect), 3 = defi-
n i t e l y  a b n o r m a l  ( b l a c k  d e f e c t ) ) .  S e g m e n t s  a f f e c t e d  b y
artefact were graded as 0. An artefact was defined as a
defect present at rest but absent at stress, matching stress
and rest defects without evidence of infarct on LGE, or
Figure 1 Myocardial first pass perfusion imaging. A, Apical (top 
row), mid (middle row) and basal (bottom row) short axis slices ac-
quired at stress (left) and rest (right). Inducible ischemia demonstrated 
by myocardial hypoenhancement, which is visible at stress (single ar-
row) and absent at rest. Fixed perfusion defects present at stress and 
rest (white double arrows) corresponding to areas of infarction on B, 
Late gadolinium enhancement images. Basal to mid lateral infarction 
(red double arrows).
A                                                  B 
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segments in the basal SA slice obtained through the left
ventricular outflow tract. Transmural and hypoenhance-
ment ischemia indices, reflecting the degree of reversible
ischemia, were calculated as a ratio of summed segmental
stress-to-rest scores, thus resulting in a grading scale of 1
= no ischemia, >1 and <3 = mild ischemia, and 3 = severe
ischemia. Abnormal ischemic segments were defined by
segmental transmural ischemia index >1. Myocardial per-
fusion ratio index (MPRi) was derived from maximal
upslopes of stress to rest myocardial contrast signal
intensity time curves, normalized to LV input (Figure 2B).
Myocardial segments in the basal slice obtained through
the LV outflow tract were excluded. Segmental infarction
was graded as 1 = normal, 2 = subendocardial infarct and
3 = transmural infarct. The infarct index was determined
by the summed segmental infarct score divided by the
number of segments analyzed.
Statistical Analyses
Within group differences in adenosine dose, hemody-
namic parameters and baseline CMR measures were
assessed using paired Student's t-test, and differences in
symptomatic response using Fisher's exact test. Repro-
ducibility was defined by the coefficient of variation
(CoV) [11]. This was determined by dividing the standard
deviation (SD) of the differences between the two mea-
surements by the average of the two measurements, and
was expressed as a percentage. For a continuous variable,
inter-study reproducibility between groups was assessed
by comparing the squared difference of the two measure-
ments between case and control subjects, with statistical
significance being assessed by the Mann-Whitney U test.
Where the squared difference of the two measurements
equaled zero, half of the next smallest value was entered.
For perfusion ordinal data, reproducibility was also
assessed by calculating the percentage of reported seg-
ments with perfect agreement in ischemia grading (none,
mild or severe) between the two studies. Bivariate corre-
lations were calculated using the Spearman correlation
coefficient to assess inter-study, inter- and intra-observer
agreement for semi-quantitative analyses. Sample sizes
were calculated to detect of varying degrees of change in
perfusion parameters at an α level of 0.05 and power of
0.9 (http://hedwig.mgh.harvard.edu/sample_size/
size.html). All data were analyzed on SPSS for Windows,
release 17.0 (SPSS Inc., Chicago, Illinois).
Results
Patient Characteristics
Twenty patients (10 low risk CAD controls and 10
patients with CAD) were recruited. Patient characteris-
tics are shown in Table 1. Patients in the control group
were younger, without prior cardiac history and had a
mean Framingham risk score of 7 ± 3%. Patients with
CAD had an average of 2.8 ± 0.4 native coronary arteries
diseased, were symptomatic with CCS class II or III
angina and the majority (n = 9, 90%) had suffered a previ-
ous myocardial infarct.
Adenosine tolerance and hemodynamic effects
Adenosine-related side effects were reported by the
majority of patients (Table 2). The adenosine infusion
Figure 2 Semi-quantitative perfusion analysis. Semi-quantitative perfusion analysis: A, Manual tracing of the endocardial (green) and epicardial 
(yellow) borders and division of the LV myocardium into 6 segments, and B, Generation of signal intensity (y axis) vs. time (x axis) curves for each myo-
cardial segment and LV (blue). Maximal upslopes for each myocardial segment, normalized to LV input, with the myocardial perfusion reserve index 
(MPRi) as the ratio of stress to rest upslopes.
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was discontinued if the patient developed severe angina,
arrhythmias, hypotension or at the patient's request.
Adenosine dosage did not differ significantly between
studies in either the case or control group, but was
administered for longer in the control compared to case
group: 2.20 ± 0.63 vs. 1.65 ± 0.55 minutes, p = 0.050.
Cardiac function and perfusion
There were no significant differences between control
and case patients for baseline LV function, volumes or
mass (Table 3). As expected, myocardial perfusion was
reduced across all measures in the CAD compared to the
control group (p < 0.020 for all measures). In the CAD
group, infarction as evidenced by LGE, was detected in
29% (45 of 156 segments) of all myocardial segments ana-
lyzed. In this group, mean global infarct index was 1.35 ±
0.34 and was comparable across all three coronary artery
territories: LAD = 1.22 ± 0.28, Cx = 1.45 ± 0.49, RCA =
1.42 ± 0.54.
Inter-study reproducibility
The two CMR studies were performed at a mean of 7.7 ±
2.2 days apart. A total of 40 scans were performed, pro-
viding 104 slices (624 segments) for analysis with equal
numbers from case and control groups. In four patients,
only two slices were analyzable due to a high heart rate
preventing acquisition of all three slices (n = 2), breath-
holding problems resulting in the apical slice being posi-
tioned too distally (n = 1) and LV outflow tract affecting
the basal slice (n = 1). In two patients, only a single slice
was analyzed due to a combination of high heart rate and
LV outflow tract acquisition in one patient, and gating
difficulties in another patient. Overall, image quality for
perfusion analysis was considered adequate in all patients
with a mean grading of 2.7 ± 0.5 for the first study and 2.8
± 0.4 for the second study. No significant differences in
image quality were detected between case and control
groups or between the two studies within each group.
LV volume and function
As shown in Table 4, inter-study reproducibility was con-
sistently high for LV volumes, ejection fraction and mass
in both case and control groups. A comparison between
control and CAD groups revealed a statistically signifi-
cant difference in reproducibility only for LV end-dia-
stolic volume, which was slightly lower for CAD
compared to control patients: 4.4% vs. 1.9% CoV for case
and control group, respectively (p = 0.018).
Qualitative myocardial perfusion analysis
Reproducibility for all qualitative measures of myocardial
perfusion was high, as demonstrated by consistently low
CoVs, high percentage of perfect agreement between
studies, and small mean difference between studies
(Table 5). Reproducibility of perfusion defect assessment
Table 1: Patient demographics.
Characteristic Case (n = 10) Control (n = 10)
Age, years 68 ± 13 (39 - 83) 56 ± 4 (52 - 62)*
Male 8 (80) 8 (80)
Vascular Risk Factors
Body mass index, kg/m2 26.6 ± 6.8 (24.0 - 33.0) 25.9 ± 3.5 (20.4 - 31.5)
Diabetes 4 (40) 0 (0)
Hypertension 4 (40) 3 (30)
Dyslipidemia† 8 (80) 1 (10)
Smoking previous/current 6 (60)/1 (10) 4 (40)/0 (0)
Framingham risk score, % - 7 ± 3 (2 - 10)
Cardiac History and Status
CCS class angina class II/III 4 (40)/6 (60) -
Myocardial infarction 9 (90) -
Number of diseased native vessels 2.8 ± 0.4 (2 - 3) -
Number of CABG operations 0.7 ± 0.5 (0 - 1) -
Number of PCI 1.3 ± 1.5 (0 - 5) -
Number of cardiac medications daily 6.9 ± 1.8 (4 - 8) -
Values are number (%) or mean ± SD (range). CABG = coronary artery bypass graft; CCS = Canadian Cardiovascular Society; PCI = 
percutaneous coronary intervention
*p < 0.05 for control vs. case.
†Presence of hyperlipidemia or lipid-lowering therapy.Chih et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:42
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by evaluation of transmural extent (CoV 8.1%) and degree
of hypoenhancement (CoV 9.4%) were both high; how-
ever, the percentage of perfect agreement between stud-
ies was higher in the former. Mean difference in number
of ischemic myocardial segment between studies was
small: -0.10 ± 0.57 for control and -0.20 ± 1.14 for CAD.
Reproducibility varied across different coronary artery
territories and was generally lower compared to global
analysis, and in the CAD compared to control group.
Semi-quantitative myocardial perfusion analysis - MPRi
The inter-study reproducibility for MPRi is shown in
Table 6. The between-study correlation for global MPRi
was moderate: Spearman's correlation coefficient r = 0.76
(p < 0.001) for all subjects, r = 0.69 (p = 0.026) for control
group and r = 0.68 (p = 0.029) for case group. MPRi CoV
was higher compared to qualitative perfusion parameters.
Regional coronary artery analysis was less reproducible
compared to global analysis in the CAD group (global
CoV 23% vs. regional 19%, p = 0.051) but comparable in
the control group (global CoV 18% vs regional CoV 19%, p
= 0.528). There was no difference in MPRi reproducibility
between case and control groups (p = 0.821).
Inter-observer and intra-observer myocardial perfusion 
reproducibility
There was good agreement for MPRi between and within
observers, with low CoVs and moderate to high correla-
tion coefficients (Table 7). Reproducibility was lower for
the CAD versus the control group for both, inter- and
intra-observer analysis, with a trend towards statistical
significance for inter-observer analysis (p = 0.056).
Sample size estimation
Within-subject variability estimates for the number of
ischemic segments, transmural ischemia index and MPRi
are shown by the standard deviation of between-study
differences for these parameters (Table 8). As shown,
clinical trials utilizing CMR to detect changes in myocar-
dial perfusion would require small sample sizes. For
example, it is estimated that a two-group parallel-design
trial would require 12 patients (6 vs. 6) to detect a mean
difference of two abnormal segments or 74 patients (37
vs. 37) to detect a 0.20 change in MPRi with 90% power
(2-alpha = 5%).
Discussion
This study demonstrates that adenosine stress perfusion
CMR has good reproducibility for both qualitative and
semi-quantitative analyses and in both patients with and
without CAD. There is limited published data available
for the reproducibility of serial myocardial perfusion
imaging modalities, especially for CMR. The inter-study
reproducibility of CMR has been demonstrated for LV
volumes, ejection fraction and mass [11,12], but only
three small studies have described the reproducibility of
perfusion CMR. Of these, one study evaluated only
observer reproducibility [8] and a second study used dob-
utamine as the pharmacological stress agent [9]. Elking-
ton et al. [7] assessed the inter-study reproducibility for
adenosine stress CMR in a cohort of 9 CAD patients and
7 healthy volunteers. They reported a CoV of 41% for
transmural MPRi and 39% (inferior segment) to 55%
Table 2: Adenosine tolerance and hemodynamic effects.
Control Case
Parameter Study 1 Study 2 p Study 1 Study 2 p
Rest
Heart rate, beats/min 60 ± 7 67 ± 10 0.411 59 ± 9 61 ± 12 0.317
Systolic BP, mmHg 130 ± 13 130 ± 11 0.912 138 ± 25 139 ± 25 0.874
Diastolic BP, mmHg 81 ± 16 82 ± 12 0.787 82 ± 11 70 ± 9 0.004
Peak stress
Heart rate, beats/min 82 ± 16 83 ± 10 0.883 76 ± 19 70 ± 12 0.063
Systolic BP, mmHg 131 ± 12 129 ± 12 0.537 130 ± 31 135 ± 20 0.671
Diastolic BP, mmHg 82 ± 16 83 ± 10 0.134 71 ± 14 71 ± 15 1.000
Adenosine infusion
Duration, min 2.3 ± 0.6 2.2 ± 0.7 0.583 1.7 ± 0.5 1.7 ± 0.6 0.204
Chest pain 4 (40) 4 (40) 0.133 5 (50) 4 (40) 0.524
Breathlessness 4 (40) 1 (10) 0.400 5 (50) 5 (50) 0.206
Flushing, headache, dizziness 8 (80) 8 (80) 0.467 3 (30) 3 (30) 0.183
Values are number (%) or mean ± SD. BP = blood pressure.Chih et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:42
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(anterior segment) for regional analyses using the nor-
malized upslope method. In contrast, we demonstrated
improved reproducibility with an MPRi CoV of 19%, 18%,
19% and 26% for global, LAD-, Cx- and RCA-territory,
respectively. Perfusion findings were generally less repro-
ducible by regional coronary artery analysis compared to
global analysis. This may be methodological as global and
regional perfusion parameters are derived by summed
segmental perfusion measurements divided by the num-
ber of segments analyzed (18 for global and 5 to 7 for
regional coronary artery territory). Hence, segment vari-
ability in measurements between studies will be diluted
to a greater extent for global versus regional analyses.
The reproducibility of qualitative analysis was better
than that for semi-quantitative analysis by MPRi: global
CoV for all subjects - 19% for MPRi, 8% for transmural
ischemia index and 9% for hypoenhancement ischemia
index. As fully automated techniques remove observer
variability, improved accuracy and uniformity of mea-
sures are expected for quantitative compared to qualita-
tive techniques. MPRi by normalized upslope analysis,
however, is at best semi-quantitative as it is dependent on
the operator to discern endocardial and epicardial bor-
ders accurately throughout the cardiac cycle. Further-
more, the occurrence of certain types of artefacts (eg.
ectopy, stress and rest slice mismatch) may impede semi-
quantitative analysis but may be overcome by an experi-
enced reporter on visual inspection.
In comparison to control subjects, patients with known
CAD were expected to have lower inter-study reproduc-
Table 3: Baseline left ventricular cardiac function and perfusion.
Parameter Control Case
Left ventricular volumes and function
Ejection Fraction, % 69 ± 8 65 ± 10
End diastolic volume, ml 146 ± 17 139 ± 40
End systolic volume, ml 47 ± 15 50 ± 27
Stroke volume, ml 99 ± 11 88 ± 21
Mass, g 113 ± 22 126 ± 23
Myocardial Perfusion - Global
Myocardial perfusion reserve index* 1.59 ± 0.58# 1.13 ± 0.21
Number of ischemic segments† 0.75 ± 1.53# 4.60 ± 2.46
Transmural ischemia index‡ 1.10 ± 0.26# 1.33 ± 0.19
Hypoenhancement ischemia index§ 1.18 ± 0.42# 1.51 ± 0.23
Infarct index|| 1.00 ± 0.00# 1.35 ± 0.34
Values are mean ± SD. Measurements are an average of the first and second study.
*Averaged segmental stress:rest maximal normalized upslopes.
†Number of myocardial segments with reversible ischemia by qualitative analysis.
‡Summed segmental transmural stress:rest score (1 = normal, 2 = subendocardial defect, 3 = transmural defect).
§Summed segmental hypoenhancement stress:rest score (1 = normal, 2 = grey defect, 3 = black defect).
||Summed segmental infarct score divided by number of segments analyzed (1 = normal, 2 = subendocardial infarct, 3 = transmural infarct).
#p < 0.020 for control vs. case.
Table 4: Inter-study reproducibility for LV volumes and function.
Coefficient of Variation (%)
Parameter Control Case p*
Left ventricular ejection fraction 2.4 2.7 0.292
Left ventricular end diastolic volume 1.9 4.4 0.018
Left ventricular end systolic volume 6.8 6.4 0.787
Left ventricular stroke volume 2.1 4.2 0.483
Left ventricular mass 4.4 4.0 0.619


























































































































Table 5: Inter-study reproducibility for qualitative perfusion parameters.
All Subjects Control Case
Parameter Mean Difference* CoV Perfect
Agreement†
Mean Difference* CoV Perfect
Agreement†
Mean Difference* CoV Perfect
Agreement†
Number of ischemic segments
Global -0.15 ± 0.88 30.6 90.7 -0.10 ± 0.57 75.7‡ 96.2 -0.20 ± 1.14 24.7 85.3
LAD -0.00 ± 0.65 72.1 89.3 -0.10 ± 0.74 210.8‡ 95.2 -0.10 ± 0.57 39.2 83.3
Circumflex -0.05 ± 0.60 78.0 90.3 -0.10 ± 0.32 210.8‡ 96.2 0.00 ± 0.82 58.3 84.3
RCA -0.07 ± 0.70 41.0 93.0 -0.10 ± 0.32 126.5‡ 97.6 -0.25 ± 0.89 27.6 88.6
Transmural ischemia index
Global -0.03 ± 0.10 8.1 90.7 -0.04 ± 0.11 9.7 96.2 -0.03 ± 0.09 7.1 85.3
LAD -0.05 ± 0.29 22.8 89.3 0.00 ± 0.15 13.3 95.2 0.11 ± 0.38 26.7 83.3
Circumflex -0.04 ± 0.21 17.6 90.3 -0.08 ± 0.18 16.5 96.2 0.01 ± 0.23 18.1 84.3
RCA -0.04 ± 0.17 13.4 93.0 -0.02 ± 0.06 5.6 97.6 -0.07 ± 0.24 16.8 88.6
Hypoenhancement ischemia index
Global -0.04 ± 0.13 9.4 81.1 -0.01 ± 0.06 5.4 94.2 -0.07 ± 0.17 11.1 67.9
LAD 0.06 ± 0.39 28.5 78.9 0.06 ± 0.14 12.1 90.3 -0.04 ± 0.25 35.1 67.2
Circumflex -0.05 ± 0.22 17.3 86.4 -0.07 ± 0.21 18.6 98.1 -0.08 ± 0.24 17.0 74.5
RCA -0.11 ± 0.25 16.8 77.9 -0.07 ± 0.14 11.0 95.2 -0.06 ± 0.28 19.2 61.4
Infarct index
Global -0.00 ± 0.06 4.7 96.0 0.00 ± 0.00 0.0 100.0 0.00 ± 0.08 6.1 94.2
LAD 0.06 ± 0.39 4.2 95.4 0.00 ± 0.00 0.0 100.0 0.00 ± 0.07 5.5 96.7
Circumflex -0.05 ± 0.22 6.4 97.1 0.00 ± 0.00 0.0 100.0 -0.03 ± 0.11 7.7 94.2
RCA -0.11 ± 0.25 9.6 95.3 0.00 ± 0.00 0.0 100.0 0.04 ± 0.17 11.8 90.9
Values are mean ± SD, CoV (%), perfect agreement (%). LAD = left anterior descending; RCA = right coronary artery.
*Mean difference between first and second study.
†Percentage of segments with perfect agreement in ischemia grading between the two studies.
‡CoV is a poor measure of reproducibility due to the average of measurements approximating zero.Chih et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:42
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ibility for a number of reasons, including increased myo-
cardial scarring from prior infarction, previous coronary
interventions (PCI and CABG) generating artefacts, and
also poorer clinical condition affecting testing due for
example, to an increased susceptibility to ischemia
induced arrhythmias or to an inability to breath-hold. As
expected, LGE was not detected in the control group but
was present in 29% of myocardial segments analyzed in
the CAD group. The mean infarct index was comparable
across all three coronary artery territories. Mean differ-
ences between studies were higher, and the proportion of
myocardial segments with perfect agreement was lower
for the CAD compared to the control group. However,
despite the presence of moderate scar burden in the CAD
compared with control group, there was no significant
difference in MPRi reproducibility between the two
groups (p = 0.850). This suggests that the presence of scar
may affect qualitative but not semi-quantitative analysis.
Intra-observer reproducibility was similar between the
two groups (p = 0.733) and there was only a trend (p =
0.056) towards lower inter-observer reproducibility for
MPRi in patients with CAD versus controls: CoV 5% vs.
13% for control and CAD, respectively. Elkington et al. [7]
reported no significant differences in reproducibility
between patients with CAD and normal subjects.
The small differences observed between the CAD and
control groups in this study may be secondary to a lower
than expected reproducibility in the control group. Our
control group was selected on the basis of low estimated
risk for CAD as defined by a Framingham risk score of
<10%. Therefore, patients in this group may have had
undiagnosed underlying CAD. Notably, the mean MPRi
was 1.59 ± 0.58 for the control group and 1.13 ± 0.21 for
the CAD group. Previous studies have reported an MPRi
of >2.0 in normal patients. Al-Saadi et al. [13] reported an
87% diagnostic accuracy (sensitivity 90%, specificity 83%)
with a MPRi cutoff value of 1.5 for detecting coronary
stenosis ≥70%, and Costa et al. [14] showed that a cutoff
of 2.04 was 85% sensitive and 49% specific in predicting
CAD with ≥50% diameter stenosis. We believe that it is
important for each centre to define its own MPRi range,
given the impact of many variables, such as contrast dose,
stress technique and sequence variations on outcome
measures.
Small SDs for between-study differences were detected
for perfusion parameters, resulting in small sample size
estimates for studies using adenosine stress CMR as a pri-
mary endpoint. Syed et al. [9] reported for dobutamine
CMR in a cohort of CCS III or IV angina patients, a
between-study difference of 1.9 myocardial segments and
an SD of 1.6, resulting in a sample size of eight being
required to detect a change in two abnormal segments.
We show similar favorable findings for adenosine CMR
with estimated sample sizes of 12 to detect an absolute
Table 6: Inter-study reproducibility for myocardial perfusion reserve index.
All Subjects Control Case
Parameter Mean Difference* CoV Mean Difference* CoV Mean Difference* CoV p†
Global 0.07 ± 0.26 18.9 -0.01 ± 0.28 17.6 0.15 ± 0.22 18.8 0.850
LAD 0.07 ± 0.25 18.4 0.03 ± 0.28 18.1 0.12 ± 0.22 18.9 0.384
Circumflex 0.11 ± 0.21 19.2 0.02 ± 0.28 17.6 0.20 ± 0.22 19.4 0.623
RCA 0.01 ± 0.34 25.6 -0.10 ± 0.32 20.7 0.12 ± 0.33 30.6 0.821
Values are mean ± SD and CoV (%). CoV = coefficient of variation; LAD = left anterior descending artery; RCA = right coronary artery.
*Mean difference between first and second study.
†Comparison of CoV between control and case.
Table 7: Inter- and intra-observer reproducibility for MPRi.
All Subjects Control Case
CoV r CoV r CoV r p*
Inter-observer 9.0 0.93† 5.0 0.99† 13.2 0.79† 0.056
Intra-observer 5.3 0.94† 4.2 0.96† 7.0 0.76† 0.733
CoV (%) = coefficient of variation. r = Spearman's correlation co-efficient.
*Comparison of CoV between control and case.
†p < 0.02Chih et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:42
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change in two ischemic myocardial segments for all sub-
jects, and of 16 for CAD patients.
Commonly used reproducibility measures have poten-
tial shortcomings and require cautious interpretation. We
used the CoV to define reproducibility, a measure that is
expressed as a percentage and not in specific units,
thereby allowing comparison of variables using different
units or scales. The CoV is calculated from the SD of the
differences in measurements divided by the average.
Given that, the denominator is dependent on the average
value of measurements, the CoV loses utility when the
average of measurements approximates zero. This limita-
tion was evident when calculating the CoVs for the num-
ber of ischemic myocardial segments in the control group
in whom this was, as expected, close to zero. The calcu-
lated high CoV of 76% reflects this drawback and should
not be interpreted as poor reproducibility. Inter-study
variability for the number of ischemic segments in con-
trol subjects is in fact low , as shown by the very small
mean difference (-0.10) and SD (0.57), as well as the high
percentage of perfect agreements (96%) between studies.
Study limitations
There are several limitations to this study. Currently,
CMR does not permit assessment of the entire myocar-
dium. Reproducibility may differ in different myocardial
regions and variation in SA slice acquisitions due to vari-
able patient positioning and breath holding can, there-
fore, affect reproducibility. Furthermore, other groups
have performed studies for reproducibility assessment
using shorter periods between studies, to minimize phys-
iological variation [11]. Similarly, perfusion CMR was
undertaken at two centers and differences in the expertise
in these centers may affect data acquisition quality.
Reproducibility may have been adversely affected by all of
these factors, but nonetheless reflects the practical chal-
lenges encountered in both clinical practice and research.
Thus, we believe that our assessment of reproducibility
by retest at one-to-two week intervals and utilizing two
separate imaging centres provides more realistic esti-
mates of the variability to be observed in a longitudinal
study. Importantly, our data is limited to a defined perfu-
sion imaging protocol and specific analysis techniques.
The use of alternative image acquisition techniques, dif-
ferent contrast agents and dosing, such as dual bolus
administration, as well as different techniques for image
analysis, such as Fermi deconvolution, may produce sig-
nificant differences in results for CMR reproducibility.
Finally our study was small, based on 10 CAD subjects
and 10 controls. This sample size was based on feasibility,
and is similar to that used in other typical studies.
Conclusion
This study demonstrates that adenosine CMR is a repro-
ducible technique with low inter-study and observer vari-
ability. Our data provides valuable information for
designing adequately powered trials to assess the efficacy
of interventions by CMR perfusion and, thus, support the
clinical and research applicability of this technique.
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Table 8: Sample size estimates for myocardial perfusion by CMR.
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Coronary artery disease - Case
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0.10 change in transmural ischemia index 0.09 38
0.20 change in myocardial perfusion reserve index 0.22 54
*Standard deviation of differences between first and second study.
†Sample size estimates for a two treatment parallel trial design.Chih et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:42
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